Oral micronized progesterone
Sponsors
New York State Psychiatric Institute, Fetal Medicine Foundation, University of British Columbia, Mayo Clinic, University of North Carolina, Chapel Hill
Conditions
Cocaine DependenceDrug resistant epilepsy
Neurosteroids, Progesterone, Drug resistant epilepsyHealthyHot FlushesMenstrual CrampsNight SweatsPerimenopausePreterm Birth
Phase 1
Phase 2
Progesterone Treatment for Cocaine-dependent Women: A Pilot Study
CompletedNCT00632099
Start: 2008-02-29End: 2012-09-30Updated: 2014-05-12
The pharmacokinetic study of progesterone and allopregnanolone in refractory epilepsy : Phase II study
Active, not recruitingTCTR20200710005
Start: 2020-07-13Target: 19Updated: 2026-08-03
Efficacy and safety of oral micronized progesterone that converts to allopregnanolone as an adjunctive treatment in refractory status epilepticus (Phase IIa study)
Active, not recruitingTCTR20200717002
Start: 2019-01-04Updated: 2026-08-03
Phase 3
Oral Progesterone for Prevention of Preterm Birth
CompletedNCT01180296
Start: 2006-11-30End: 2009-01-31Updated: 2019-02-18
Progesterone for Perimenopausal Night Sweats
CompletedNCT01464697
Start: 2011-10-31End: 2018-06-01Updated: 2019-12-16
Oral Micronized Progesterone Effects on Perimenopausal Menstrual Flow
CompletedNCT02779582
Start: 2015-06-30End: 2018-06-01Updated: 2020-03-24